Abstract:Genome-wide association studies (GWAS) have been successful in finding associations between specific genetic variants and cancer susceptibility in human populations. These studies have identified a range of highly statistically significant associations between single nucleotide polymorphisms (SNPs) and susceptibility to development of a range of human tumors. However, the effect of each SNP in isolation is very small, and all of the SNPs combined only account for a relatively minor proportion of the total genetic risk (5-10%). There is therefore a major requirement for alternative routes to the discovery of genetic risk factors for cancer. We have previously shown using mouse models that chromosomal regions harboring susceptibility genes identified by linkage analysis frequently exhibit allele-specific genetic alterations in tumors. We demonstrate here that the Fbxw7 gene, a commonly mutated gene in a wide range of mouse and human cancers, shows allele-specific deletions in mouse lymphomas and skin tumors. Lymphomas from three different F1 hybrids show 100% allele-specificity in the patterns of allelic loss. Parental alleles from 129/Sv or Spretus/Gla mice are lost in tumors from F1 hybrids with C57BL/6 animals, due to the presence of a specific non-synonymous coding sequence polymorphism at the N-terminal portion of the gene. A specific genetic test of association between this SNP and lymphoma susceptibility in interspecific backcross mice showed a significant linkage (p = 0.001), but only in animals with a functional p53 gene. These data therefore identify Fbxw7 as a p53-dependent tumor susceptibility gene. Increased p53-dependent tumor susceptibility and allele-specific losses were also seen in a mouse skin model of skin tumor development. We propose that analysis of preferential allelic imbalances in tumors may provide an efficient means of uncovering genetic variants that affect mouse and human tumor susceptibility.

Control Of Genomic Instability And Epithelial Tumor Development By The P53-Fbxw7/Cdc4 Pathwayle

Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

Allele-Specific Deletions in Mouse Tumors Identify Fbxw7 As Germline Modifier of Tumor Susceptibility

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

Ordered and deterministic cancer genome evolution after p53 loss

Modeling the Etiology of p53-mutated Cancer Cells

Mouse models to investigate in situ cell fate decisions induced by p53

Gain of Function of P53 Cancer Mutants in Disrupting Critical DNA Damage Response Pathways

p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice

p53 and FBXW7: Sometimes Two Guardians Are Worse than One

Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation

Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice

Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control?

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network

Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer.

Genetic and Stochastic Influences Upon Tumor Formation and Tumor Types in Li-Fraumeni Mouse Models

PTEN C-terminal Deletion Causes Genomic Instability and Tumor Development.

Gliomagenesis Arising From Pten- And Ink4a/Arf-Deficient Neural Progenitor Cells Is Mediated By The P53-Fbxw7/Cdc4 Pathway, Which Controls C-Myc

Loss of p53 tumor suppression function drives invasion and genomic instability in models of murine pancreatic cancer